nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma
|
Chen, Zhenwen |
|
|
148 |
1 |
p. 267-278 |
artikel |
2 |
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma
|
Zinzani, Pier Luigi |
|
|
148 |
1 |
p. 177-190 |
artikel |
3 |
Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children
|
Wetzel, Laura |
|
|
148 |
1 |
p. 255-265 |
artikel |
4 |
CMTM6, a potential immunotherapy target
|
Liang, Jie |
|
|
148 |
1 |
p. 47-56 |
artikel |
5 |
Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
|
Jurkovic Mlakar, Simona |
|
|
148 |
1 |
p. 87-88 |
artikel |
6 |
Correction to: Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries
|
Efremov, Ljupcho |
|
|
148 |
1 |
p. 279 |
artikel |
7 |
Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified
|
Ota, Takahiro |
|
|
148 |
1 |
p. 281-282 |
artikel |
8 |
3D mixed-reality visualization of medical imaging data as a supporting tool for innovative, minimally invasive surgery for gastrointestinal tumors and systemic treatment as a new path in personalized treatment of advanced cancer diseases
|
Wierzbicki, Ryszard |
|
|
148 |
1 |
p. 237-243 |
artikel |
9 |
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
|
Zandi, Zahra |
|
|
148 |
1 |
p. 57-70 |
artikel |
10 |
Estimating the global burden of Epstein–Barr virus-related cancers
|
Wong, Yide |
|
|
148 |
1 |
p. 31-46 |
artikel |
11 |
Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact
|
Cabral de Carvalho Corrêa, Débora |
|
|
148 |
1 |
p. 107-119 |
artikel |
12 |
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
|
Jurkovic Mlakar, Simona |
|
|
148 |
1 |
p. 71-86 |
artikel |
13 |
Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study
|
Thong, Melissa S. Y. |
|
|
148 |
1 |
p. 155-162 |
artikel |
14 |
Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI
|
Niu, Shuxian |
|
|
148 |
1 |
p. 97-106 |
artikel |
15 |
Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
|
Bhatti, Abu Bakar Hafeez |
|
|
148 |
1 |
p. 245-253 |
artikel |
16 |
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications
|
Raja, Aroosha |
|
|
148 |
1 |
p. 15-29 |
artikel |
17 |
Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion
|
Zeng, Jie |
|
|
148 |
1 |
p. 137-153 |
artikel |
18 |
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
|
Ferrera, Giuseppe |
|
|
148 |
1 |
p. 89-95 |
artikel |
19 |
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective
|
Chen, Yu-Chi |
|
|
148 |
1 |
p. 1-14 |
artikel |
20 |
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
|
Ozaki, Shuji |
|
|
148 |
1 |
p. 191-203 |
artikel |
21 |
Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10–pyruvate carboxylase axis
|
Wang, Chen |
|
|
148 |
1 |
p. 121-135 |
artikel |
22 |
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
|
Steinhardt, Maximilian J. |
|
|
148 |
1 |
p. 205-214 |
artikel |
23 |
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis
|
Park, Sohyun |
|
|
148 |
1 |
p. 215-224 |
artikel |
24 |
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
|
Swiha, Mina M. |
|
|
148 |
1 |
p. 225-236 |
artikel |
25 |
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns
|
Bai, Rilan |
|
|
148 |
1 |
p. 163-176 |
artikel |